Skip to main content
Premium Trial:

Request an Annual Quote

Upstate to License RheoGene s Gene Regulation Technology

NEW YORK, April 29 (GenomeWeb News) - Rheogene, of Norristown, Pa., said today that it has granted a nonexclusive license to Upstate USA, of Charlottesville, Va., to develop research test kits based on RheoGene's inducible gene regulation system.

 

Under the terms of the agreement, Upstate will use RheoGene's Rheoswitch system in combination with Upstate's RNAi and antibody research kits. Upstate also obtains a nonexclusive license to RheoGene's RheoPlex multiple gene regulation technology, the company said.

 

Financial terms of the deal were not provided.

The Scan

Unwrapping Mummies' Faces

LiveScience reports that Parabon NanoLabs researchers have reconstructed how three Egyptian mummies may have looked.

Study on Hold

The Spectrum 10K study has been put on hold due to a backlash, leading the researchers to conduct consultations with the autism community, Nature News reports.

Others Out There Already

Reuters reports that Sanofi is no longer developing an mRNA-based vaccine for SARS-CoV-2.

PNAS Papers on GWAS False Discovery, PRAMEF2 Role in Tumorigenesis, RNA Virus Reverse Genetics

In PNAS this week: strategy to account for GWAS false-discovery rates, role of PRAMEF2 in cancer development, and more.